HomeClinical TopicsFDA approvals—July 11-12, 2016

FDA approvals—July 11-12, 2016

On July 12, the Food and Drug Administration (FDA) approved Xiidra (lifitegrast ophthalmic solution) for the treatment of signs and symptoms of dry eye disease. Read more

 

On July 11, the FDA approved the first focused ultrasound device, ExAblate Neuro, to treat essential tremor in patients who have not responded to medication. Read more

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Recent Content

For Nurse Practitioners

NP taking pregnant woman's blood pressure

AHA: It’s Safe to Treat High Blood Pressure During Pregnancy

High blood pressure during pregnancy can present significant risks to mother and child, but practitioners have sometimes be hesitant to prescribe blood pressure medication...